Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Title Grant Type Focus Area Country Application Due Date Innovative digital educational channels in Oncology for health care professionals or patients to increase local awarenessRelease Date:Education Oncology Spain Individualized Menopause CareRelease Date:Education Internal Medicine USA Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin DiseasesRelease Date:Quality Improvement Inflammation & Immunology Japan Promoting Appropriate Diagnosis and Treatment of Migraine CareRelease Date:Education Internal Medicine Japan Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)Release Date:Research Inflammation & Immunology All Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates Increasing Understanding of the Evolving Hemophilia Treatment LandscapeRelease Date:Education Rare Disease USA Non-Muscle Invasive Bladder Cancer Emerging Markets Needs AssessmentRelease Date:Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory DiseasesRelease Date:Education Inflammation & Immunology All Juvenile Idiopathic Arthritis (JIA) Patient EducationRelease Date:Education Inflammation & Immunology USA Updates on RSV in Older Adults for PharmacistsRelease Date:Education Vaccines USA PARP-inhibitor Combination Treatments in Prostate Cancer, a Global PerspectiveRelease Date:Education Oncology All